Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)

Completed

• Conditions: Hypertension

• Registration Number: NCT02394392
• Lead Sponsor: Boryung Pharmaceutical Co., Ltd

Brief Summary

1. Investigate the clinical characteristics, medication satisfaction and quality of life of anti-hypertensive drugs in Korean hypertensive patients

2. Observe the changes of medication satisfaction and compliance in patients after switchting to Fimasartan

Detailed Description

Not available

Study Timeline

• Study Start: 2014-07
• Study First Submitted: 2015-03-10
• Study First Submitted QC: 2015-03-19
• Study First Posted: 2015-03-20
• Primary Completion: 2015-08
• Study Completion: 2015-10
• Status Verified: 2016-07
• Last Update Submitted: 2016-07-07
• Last Update Posted: 2016-07-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12691

Inclusion Criteria

Step1

• Over 20 years old
• Essential hypertensive patients who taking anti-hypertensive drugs during previous 1 month

Step2

• Patients does not taking Fimasartan
• Patient's medication satisfaction score under 4

Exclusion Criteria

• Patients with secondary hypertension
• Patients with orthostatic hypotension who has sign and symptom
• Patients with known severe or malignancy retinopathy
• Patients with significant investigations; abnormal renal function
• Childbearing and breast-feeding women
• Patients with history of allergic reaction to any angiotensin II antagonist

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
quality of life questionnaire for hypertension	up to 1 month
medication satisfaction questionnaire	up to 8 weeks

Secondary Outcome Measures

Name	Time	Method
Drug compliance questionnaire	up to 8 weeks

Trial Locations

Locations (1)

Korea university Guro hospital; 🇰🇷 Seoul, Korea, Republic of